Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01009437 · ClinicalTrials.gov registry record · Phase 1

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

A Phase 1 study of Breast Cancer, sponsored by Masonic Cancer Center, University of Minnesota.

Completed
Registry status
Phase 1
Development phase
28
Enrollment target
2
Study locations

NCT01009437 is a Phase 1 study of Breast Cancer that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 28 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01009437, a Phase 1 study of Breast Cancer, has completed, sponsored by Masonic Cancer Center, University of Minnesota.

COMPLETED
Registry status
Phase 1
Development phase
28 participants
Enrollment target
2
Study locations

Study Summary

RATIONALE: Ritonavir may stop the growth of tumor cells by blocking some of the enzymes needed for cancer cell growth. Studying samples of blood and tissue from patients with breast cancer in the laboratory may help doctors learn more about the effects of ritonavir on biomarkers involved in breast cancer growth. PURPOSE: This phase I/II trial is studying the best dose of ritonavir and its effects on biomarkers in women undergoing surgery for newly diagnosed breast cancer.

Conditions Studied

Breast Cancer

Interventions

  • PROCEDURE therapeutic conventional surgery
  • DRUG ritonavir

Study Locations (2)

Minnesota

  • Masonic Cancer Center, University of Minnesota - Minneapolis

Pennsylvania

  • The Kimmel Cancer Center at Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2010-05-26
Est. Completion 2014-07
Phase Phase 1

Sponsor

Masonic Cancer Center, University of Minnesota

249 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01009437

The ClinicalTrials.gov registry entry for NCT01009437 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which therapeutic conventional surgery is the first listed.

NCT01009437 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01009437 about?

NCT01009437 is a clinical study titled "Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer". RATIONALE: Ritonavir may stop the growth of tumor cells by blocking some of the enzymes needed for cancer cell growth. Studying samples of blood and tissue from patients with breast cancer in the laboratory may help doctors learn more about the effects of ritonavir on biomarkers involved in breast c...

What is the current status of trial NCT01009437?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2010-05-26. Estimated completion is 2014-07.

What conditions does trial NCT01009437 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT01009437?

The interventions under investigation include: therapeutic conventional surgery (PROCEDURE), ritonavir (DRUG).

Who is sponsoring clinical trial NCT01009437?

This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01009437 being conducted?

This trial has 2 study locations across Minnesota, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.